Navigation Links
New TB Vaccine Passes Safety Trial
Date:4/8/2009

Experimental preparation was tested in people with latent infection,,

WEDNESDAY, April 8 (HealthDay News) -- An experimental tuberculosis vaccine called MVA85A proved safe in a small phase I clinical trial.

The study included 12 people with latent tuberculosis infection, which, when re-activated, can cause full-blown TB. It's believed that about a third of the world's population has this latent infection. The participants, who had no other complicating factors, such as hepatitis or HIV, were given the vaccine and then followed for a year.

The researchers concluded that the vaccine was safe, did not produce any immunopathology and was immunogenic in the patients. Some participants had side effects that included fever, headache, fatigue and mild concerns at the site of the vaccination.

The findings appear in the April 15 issue of the American Journal of Respiratory and Critical Care Medicine.

This study could be an important step forward in efforts to introduce a new vaccine to fight TB, according to the researchers, led by Dr. Helen McShane, of the University of Oxford in England. They noted that any new vaccine must be developed with latent TB infection in mind because it might decrease the effectiveness of new vaccines or worsen vaccine-related side effects.

"A more effective vaccine regimen than the currently available bacillus Calmette-Guerin would have a major impact on the global TB burden and, ultimately, will be the most efficient way to control this pandemic," the researchers wrote.

They noted that larger trials of the vaccine "are needed in TB endemic areas to assess the efficacy of this vaccine against the development of TB disease, but these results are very encouraging and justify the further development of this vaccine."

More information

The American Lung Association has more about

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay
2. Hard To Treat Diseases (HTDS) Offers Hepatitis A Vaccine in India
3. U.S. Adults Needlessly Vulnerable to Vaccine-Preventable Diseases, According to New Report
4. Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis
5. Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
6. Hard to Treat Diseases (HTDS) clinical trial protocol for MMR Vaccine expected Q2 2009
7. Oral Yogurt Vaccine Could Blunt Ouch Factor
8. HPV Data May Aid Vaccines Effectiveness
9. Saving Vaccines with SensoTech's Breakthrough in Vaccine Temperature Monitoring
10. HARD TO TREAT DISEASES (HTDS) Influenca Vaccine (MEVAC-FLU) Enters Chilean Market
11. TB vaccine developed at McMaster University in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New TB Vaccine Passes Safety Trial
(Date:4/27/2015)... 27, 2015 Climate change predictions are ... on the number of variables used and the availability ... scientists, water researcher Gerald Pollack, PhD, and Climatologist L.DeWayne ... of Water® radio show, noted three potential weaknesses that ... None of these individuals dispute that Earth’s climate is ...
(Date:4/27/2015)... Texas (PRWEB) April 27, 2015 ... Review, H1 2015” provides comparative analysis on ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report on H1 ... 26 market data tables and 14 figures, ...
(Date:4/27/2015)... Denver, Colorado (PRWEB) April 27, 2015 ... a ground-breaking solution to a problem that has ... marketing and advertising campaigns: by announcing the ... engine of its kind. , Officially launched ... industry and was created to index only marijuana-related ...
(Date:4/27/2015)... 2015 The Sanford J. Grossman Charitable ... Grossman, PhD, has committed $3 million to establish the ... Inflammatory Bowel Disease at the Icahn School of Medicine ... personalized medicine for treatment of Crohn’s disease, with the ... Crohn’s Disease, a chronic inflammatory disorder of the bowel ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 The ... in providing members with applied business information and intelligence, ... Insider,” a weekly email newsletter for its more than ... existing health care legislative news sources in that it ... to the business of radiology. The newsletter is produced ...
Breaking Medicine News(10 mins):Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Essential Thrombocythemia Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 2Health News:The WeedLife Network debuts its ground-breaking WeedLIVE cannabis industry search engine 3Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 2Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 3Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2
... Sara and Susan G. Komen for the Cure, San Diego Unite ... Word is spreading about YOGA 4 THE CURE. In ... to stretch, deep breathe and meditate. Along with getting fit ... for breast cancer. Susan G. Komen for the Cure, San Diego ...
... The Brooklyn Autism Center (BAC) ... Autism Spectrum Disorders. The program was founded by ... to provide high quality, effective educational services for ... News Release, go to: http://www.prnewswire.com/mnr/brooklynautismcenter/37761/ BAC ...
... April 20 iVisit, LLC is proud to ... place in the Fourth Annual CTIA Emerging Technologies (E-Tech) ... are designed to give industry recognition and exposure to ... applications were submitted and reviewed by a panel of ...
... Mass., April 20 Millstone Medical Outsourcing announced today the ... MA. Millstone will hold an Open House on ... and local dignitaries, and friends of the company. Congressman ... to attend. Massachusetts Governor Deval Patrick and Senator John ...
... have been saying for years that their kids are "addicted" ... State University psychology professor is the first to actually report ... national sample of youth, aged 8 to 18. , In ... 8-18), ISU Assistant Professor of Psychology Douglas Gentile found nearly ...
... continuing clinical problem and socio-economic burden with diabetic foot ulcers ... in Bristol have found that human foetal stem cells can ... a model of type 1 diabetes. , The researchers ... been grown mimicked the wound-healing ability of the cells, suggesting ...
Cached Medicine News:Health News:YOGA 4 THE CURE Raises $1,000 for Breast Cancer 2Health News:YOGA 4 THE CURE Raises $1,000 for Breast Cancer 3Health News:Photos: Questions About Autism? The Brooklyn Autism Center Academy Can Help. 2Health News:Photos: Questions About Autism? The Brooklyn Autism Center Academy Can Help. 3Health News:iVisit Rx Wins 1st Place in CTIA Wireless 2009(R) CTIA E-Tech Awards for Innovation in Enterprise & Vertical - Healthcare Solution 2Health News:iVisit Rx Wins 1st Place in CTIA Wireless 2009(R) CTIA E-Tech Awards for Innovation in Enterprise & Vertical - Healthcare Solution 3Health News:Millstone Medical Outsourcing Celebrates New Fall River Facility, Designed to Meet Demand for Advanced Inspection, Clean Room Services 2Health News:National study finds nearly 1 in 10 youth gamers addicted to video games 2Health News:Human stem cells promote healing of diabetic ulcers 2Health News:Human stem cells promote healing of diabetic ulcers 3
(Date:4/27/2015)... , April 27, 2015 BioLife ... developer, manufacturer and marketer of proprietary clinical grade ... and precision thermal shipping products for cells ... the United States Food and Drug Administration has confirmed ... Thawing Media products.  While not an endorsement nor approval ...
(Date:4/27/2015)... -- TWi Pharmaceuticals, Inc. ("TWi") today announced that ... Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals ... (individually and collectively, "Takeda") to settle and dismiss ... dexlansoprazole delayed release capsules for oral administration in ... New Drug Application for TWi,s generic product is ...
(Date:4/26/2015)... -- Ikonopedia announced today that its breast imaging reporting ... for use by BelleBridge, which provides telemedicine services ... Ikonopedia will showcase its suite of structured reporting ... Breast Imaging Symposium in Orlando, Fla. ... BelleBridge is an innovative telemedicine provider ...
Breaking Medicine Technology:BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 2BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 3BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 4TWi Announces Settlement with Takeda on Dexilant(R) Litigation 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4
... American Oriental Bioengineering, Inc. (NYSE: AOB ), ... improving health through the development, manufacture and commercialization of ... ("OTC") products, today announced that it plans to release ... 2011, after the market closes. The ...
... National Community Pharmacists Association (NCPA) CEO, B. Douglas ... by the Preserve Community Pharmacy Access NOW! ... morning, culminating an advocacy push that brought community pharmacists ... the Federal Trade Commission (FTC) to reject the proposed ...
Cached Medicine Technology:American Oriental Bioengineering to Announce Third Quarter 2011 Financial Results on November 8, 2011 2Lawmakers, Pharmacists Rally Against Express Scripts-Medco Merger Proposal at U.S. Capitol 2Lawmakers, Pharmacists Rally Against Express Scripts-Medco Merger Proposal at U.S. Capitol 3
Aaron 950 is a high frequency desiccator with cut....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: